Haas Jason sold LGND
June 12, 2026 · Form 4 insider transaction
Haas Jason sold 3,461 shares of Ligand Pharmaceuticals Incorporated at $256.08 per share, a transaction worth $886.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,461
Price
$256.08
Total value
$886.3K
InsiderHaas Jason
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 12, 2026
Filing dateJune 15, 2026
Shares owned after4,981
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $256.0000 to $256.5100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.